Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study-Reference-Cited by-同舟云学术

Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study

Published:2017-01-10 Issue:1 Volume:17 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Bieh Kingsley Lezor,Weigel Ralf,Smith Helen

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-016-2114-x.pdf

Reference29 articles.

1. World Health Organization. Global Tuberculosis Report 2014. Geneva: World Health Organization; 2014.

2. Falzon D, Jaramillo E, Wares F, Zignol M, Floyd K, Raviglione MC. Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data. Lancet Infect Dis. 2013;13(8):690–7.

3. World Health Organization. Towards universal access to diagnosis and treatment of multi-drug resistant Tuberculosis:WHO progress report 2011. Geneva: WHO; 2011.

4. World Health Organization. Global tuberculosis report 2015. 2015.

5. World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis 2016 update. 2016.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration Challenges and Opportunity of Implementing Non-Communicable Disease Screening Intervention with Tuberculosis Patient Care: A Mixed Implementation Study;Risk Management and Healthcare Policy;2023-11

2. Drug resistant tuberculosis treatment service alignment with health seeking behaviour in selected states in Nigeria;Journal of Public Health and Epidemiology;2023-07-31

3. Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB);SSM - Qualitative Research in Health;2022-12

4. Pretreatment attrition and treatment initiation delay among rifampicin-resistant tuberculosis patients in Lagos, Nigeria: a retrospective cohort study;Transactions of The Royal Society of Tropical Medicine and Hygiene;2022-06-16

5. The Role of GeneXpert MTB/RIF in Reducing Treatment Delay Among Multidrug Resistance Tuberculosis Patients: A Propensity Score Matched Analysis;Infection and Drug Resistance;2022-01